Solving the taxing problems of taxanes?
European Pharmaceutical Review
NOVEMBER 4, 2022
Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour While highly effective, taxanes also exhibit several of the typical limitations associated with systemic chemotherapies. tumour effects.
83 
Let's personalize your content